Publication Name	World Journal of Clinical Oncology
Manuscript ID	57424
Country	Romania

Received	2020-06-08 12:27
Peer-Review Started	2020-06-08 12:28
To Make the First Decision
Return for Revision	2020-09-18 16:45
Revised	2020-09-27 17:03
Second Decision	2020-10-20 10:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-10-20 21:47
Articles in Press	2020-10-20 21:47
Publication Fee Transferred
Edit the Manuscript by Language Editor	2020-11-02 08:15
Typeset the Manuscript	2020-12-11 16:05
Publish the Manuscript Online	2020-12-18 12:27

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Fluoropyrimidine-induced cardiotoxicity
Manuscript Source	Unsolicited Manuscript
All Author List	Andrada Larisa Deac, Claudia Cristina Burz, Ioana Corina Bocsan and Anca Dana Buzoianu
Funding Agency and Grant Number
Corresponding Author	Andrada Larisa Deac, MD, Doctor, Doctor, Department of Medical Oncology, "Prof.Dr.Ion Chiricuta" Oncology Institute from Cluj-Napoca, Republicii Street, Cluj-Napoca 400015, Cluj, Romania. andrada.deac@gmail.com
Key Words	Fluoropyrimidines; Cancer treatments; Cardiotoxicity; Rechallenge; Prevention; Antidote
Core Tip	There are several reviews and cases which showed fluoropyrimidine-induced cardiotoxicity. However, this mini-review includes useful information about clinical manifestations, pathophysiological mechanisms, diagnosis, and management of fluoropyrimidine cardiotoxicity.
Publish Date	2020-12-18 12:27
Citation	Deac AL, Burz CC, Bocsan IC, Buzoianu AD. Fluoropyrimidine-induced cardiotoxicity. World J Clin Oncol 2020; 11(12): 1008-1017
URL	https://www.wjgnet.com/2218-4333/full/v11/i12/1008.htm
DOI	https://dx.doi.org/10.5306/wjco.v11.i12.1008

Full Article (PDF)	WJCO-11-1008.pdf
Full Article (Word)	WJCO-11-1008.docx
Manuscript File	57424_Auto_Edited-Webster J.docx
Answering Reviewers	57424-Answering reviewers.pdf
Audio Core Tip	57424-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	57424-Conflict-of-interest statement.pdf
Copyright License Agreement	57424-Copyright license agreement.pdf
Peer-review Report	57424-Peer-review(s).pdf
Scientific Misconduct Check	57424-Scientific misconduct check.pdf
Scientific Editor Work List	57424-Scientific editor work list.pdf
CrossCheck Report	57424-CrossCheck report.pdf